“…The increase of antibiotic-resistant bacterial infections over the last decades has prompted the search for novel antimicrobial molecules. Antimicrobial peptides (AMPs), such as human defensins and cathelicidins, have become outstanding candidates to fight infection due to their properties and the low risk of developing resistance [1,2]. They can be modified by in-silico models to improve their biological activity and selectivity [3].…”